RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it.
about
RSK3: A regulator of pathological cardiac remodelingGene-microRNA network module analysis for ovarian cancer.RAF1 mutations in childhood-onset dilated cardiomyopathyHydrogen sulfide anion regulates redox signaling via electrophile sulfhydrationPZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.Genetics of human cardiovascular diseaseElevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac HypertrophyBRAF gene: From human cancers to developmental syndromes.Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.Raf-mediated cardiac hypertrophy in adult DrosophilaCellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats.The Spatiotemporal Limits of Developmental Erk Signaling.Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload.Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog.Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome.
P2860
Q28086916-52332969-6779-4EC3-A857-A1660CA103E7Q30836108-C2171BC4-54AA-4EBE-AAA5-209EEDB1B140Q33726801-9A95AD7C-94CA-4C19-B247-20F1BFA2BD6EQ34009617-F229DF5F-93CE-459A-8AF8-CF92F4355EE0Q34056454-242A87DB-58BF-46E2-BE1B-1C2B60658EE1Q34261931-2204ACBF-DDE9-489C-8007-0A0B43C3B816Q35757606-0DE1D9AA-BEBC-4186-B5F0-35DDD82064DAQ35802430-DDF73DED-699E-43EE-9A16-1AA68B1545DAQ36483309-F24F1AEC-C8BD-488C-96C4-CC3D665CC88DQ36510904-B92A0E7B-CD41-489B-B185-0C21C6E5A62BQ36981830-239A49A8-CCEC-4954-ABB8-7A11C8D3430DQ41976316-25E815E3-B420-4961-A1B4-D3B50E5929B4Q50068185-27776721-5E2B-4D5C-99F2-508367979C53Q50459418-492EECEB-BDBF-4C88-8950-76E605B3736BQ51239755-ACB93501-52EE-4ABE-9AF2-CBE1CCAEE446Q52692039-8B09FB2D-2ACF-40A2-96C8-2B8E55EBDC99Q53809069-CF4C7B0A-9BA0-4376-9FE8-F36C59361F35Q54356148-D37ED891-EB1E-4653-9C9A-15C472BF3E45
P2860
RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
RAS signaling pathway mutation ...... to and out of the thick of it.
@en
RAS signaling pathway mutation ...... to and out of the thick of it.
@nl
type
label
RAS signaling pathway mutation ...... to and out of the thick of it.
@en
RAS signaling pathway mutation ...... to and out of the thick of it.
@nl
prefLabel
RAS signaling pathway mutation ...... to and out of the thick of it.
@en
RAS signaling pathway mutation ...... to and out of the thick of it.
@nl
P2860
P356
P1476
RAS signaling pathway mutation ...... to and out of the thick of it.
@en
P2093
Bruce D Gelb
P2860
P304
P356
10.1172/JCI46399
P407
P577
2011-02-21T00:00:00Z